Citation: Rd. Hull et al., Low-molecular-weight heparin prophylaxis: Preoperative versus postoperative initiation in patients undergoing elective hip surgery, THROMB RES, 101(1), 2001, pp. V155-V162
Authors:
Hull, RD
Pineo, GF
Stein, PD
Mah, AF
MacIsaac, SM
Dahl, OE
Ghali, WA
Butcher, MS
Brant, RF
Bergqvist, D
Hamulyak, K
Francis, CW
Marder, VJ
Raskob, GE
Citation: Rd. Hull et al., Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty - A systematic review, ARCH IN MED, 161(16), 2001, pp. 1952
Authors:
Hull, RD
Pineo, GF
Stein, PD
Mah, AF
MacIsaac, SM
Dahl, OE
Butcher, M
Brant, RF
Ghali, WA
Bergqvist, D
Raskob, GE
Citation: Rd. Hull et al., Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review, ANN INT MED, 135(10), 2001, pp. 858-869
Authors:
Hull, RD
Raskob, GE
Brant, RF
Pineo, GF
Elliott, G
Stein, PD
Gottschalk, A
Valentine, KA
Mah, AF
Citation: Rd. Hull et al., Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism, ARCH IN MED, 160(2), 2000, pp. 229-236
Authors:
Hull, RD
Pineo, GF
Francis, C
Bergqvist, D
Fellenius, C
Soderberg, K
Holmqvist, A
Mant, M
Dear, R
Baylis, B
Mah, A
Brant, R
Citation: Rd. Hull et al., Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients - A double-blind, randomized comparison, ARCH IN MED, 160(14), 2000, pp. 2199-2207
Authors:
Hull, RD
Pineo, GF
Francis, C
Bergqvist, D
Fellenius, C
Soderberg, K
Holmqvist, A
Mant, M
Dear, R
Baylis, B
Mah, A
Brant, R
Citation: Rd. Hull et al., Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients - A double-blind, randomized comparison, ARCH IN MED, 160(14), 2000, pp. 2208-2215
Authors:
Hull, RD
Raskob, GE
Brant, RF
Pineo, GF
Stein, PD
Mah, AF
Citation: Rd. Hull et al., Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism? In reply, ARCH IN MED, 160(13), 2000, pp. 2065-2066
Citation: Rd. Hull et al., A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis, ACUTE PULMONARY EMBOLISM, 2000, pp. 161-174
Citation: Gf. Pineo et Rd. Hull, Prophylaxis of venous thromboembolism following orthopedic surgery: Mechanical and pharmacological approaches and the need for extended prophylaxis, THROMB HAEM, 82(2), 1999, pp. 918-924
Citation: Rd. Hull et Gf. Pineo, Extended prophylaxis against venous thromboembolism following total hip and knee replacement, HAEMOSTASIS, 29, 1999, pp. 23-31
Authors:
Hull, RD
Brant, RF
Pineo, GF
Stein, PD
Raskob, GE
Valentine, KA
Citation: Rd. Hull et al., Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement, ARCH IN MED, 159(2), 1999, pp. 137-141
Citation: Ge. Raskob et al., Evidence-based evaluation of preoperative vs postoperative use of low-molecular-weight heparin in preventing deep vein thrombosis in elective hip surgery - Reply, ARCH IN MED, 159(14), 1999, pp. 1623-1623
Citation: Gf. Pineo et Rd. Hull, Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism, BAIL CLIN H, 11(3), 1998, pp. 621-637
Citation: Rd. Hull et al., Heparin and low-molecular-weight heparin therapy for venous thromboembolism - The twilight of anticoagulant monitoring, INT ANGIOL, 17(4), 1998, pp. 213-224
Citation: Rd. Hull et al., The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects - Low-molecular-weight heparin versus unfractionated heparin, HAEMOSTASIS, 28, 1998, pp. 8-16